tci Part B Insider - 2005 Issue 14

PHYSICIAN NOTES: More Patients Will Hear Good News About Cochlear Implants

Triple-threat drug combo will target nausea and vomitingMedicare expanded its coverage for cochlear implant devices to include patients with open-set recognition test scores of less than 40 percent correct, the Centers for Medicare and Medicaid Services announced. Previously, CMS required test scores of 30 percent correct or less for coverage. Also, Medicare will cover the devices for patients with test scores between 40 and 60 percent if they participate in an approved clinical trial. Separately, CMS will cover a third drug to prevent nausea and vomiting among at-risk chemotherapy patients. The additional coverage for aprepitant, also known as Emend...

To read the full article, sign in and subscribe to tci Part B Insider.

Thank you for choosing Find-A-Code, please Sign In to remove ads.